This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Belgium
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This study is completed in the United States, in Belgium, and in Japan. It is testing safety and Efficacy of Intranasal Esketamine for treatment-resistant depression.
This study is completed in Brazil. It is testing antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial for treatment-resistant depression.
This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.
In Boston
Why is this study shown?
This study is directly about Depression.
Depression, BipolarityDrugFrom 18 Years to 65 Years
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
